Knowledge Graph Therapy Scoring via Granular Document Analysis

The patent introduces an automated literature analysis system as an intermediary between published literature and subject-matter experts. This system uses natural language processing and machine learning to pre-analyze, filter, and synthesize medical literature, providing structured summaries and evidence-based recommendations that experts can then validate. This intermediary processing significantly reduces the time and computational resources required while maintaining recommendation reliability.

The patent replaces the manual mechanical review process with an automated computational system. Instead of experts manually reading and analyzing numerous published studies, the system uses algorithms to automatically extract relevant data, compare therapies, and generate evidence-based recommendations. This substitution dramatically reduces review time and costs while scaling to handle expanding literature volumes.

The patent implements a self-service automated analysis system that performs literature review tasks independently without requiring extensive expert intervention. The system autonomously retrieves, analyzes, and synthesizes medical literature using machine learning models, providing draft recommendations that require minimal expert validation. This self-service approach dramatically reduces the expensive human expert hours required while maintaining recommendation quality through algorithmic rigor.

The patent replaces expensive manual expert review with automated computational analysis. Machine learning algorithms process and interpret medical literature at a fraction of the cost of human experts, while still extracting meaningful clinical insights. This substitution reduces operational costs while scaling to handle expanding literature volumes that would be prohibitively expensive to review manually.

The patent transforms the static, periodic guideline update process into a dynamic, continuous system. The automated analysis system continuously monitors and processes new published literature in real-time, automatically detecting when evidence supports guideline modifications. This dynamic approach ensures guidelines remain current and adaptable to new discoveries while maintaining consistency through systematic, algorithm-driven evaluation rather than ad-hoc updates.

The patent implements continuous feedback loops where the automated system constantly compares new literature against existing guidelines, identifying discrepancies and evidence-based improvements. This feedback mechanism ensures guidelines are systematically updated to reflect current evidence while maintaining internal consistency. The system provides traceable feedback on why recommendations are made, allowing for transparent and reliable guideline evolution as literature expands.

The patent segments the document relevance assessment into multiple granular dimensions: patient demographics, disease characteristics, intervention details, outcomes, and study quality. Instead of relying on a single broad criteria match, the system analyzes each dimension separately and weights them according to patient-specific needs. This segmented approach maintains ease of operation through structured analysis while dramatically improving measurement precision by capturing nuanced patient-therapy matches that broad criteria would miss.

The patent applies local quality by tailoring the relevance analysis to each specific patient context rather than applying uniform criteria. The system adjusts the weight and importance of different document attributes based on the individual patient's characteristics, disease severity, and treatment goals. This localized approach improves precision by making each relevance assessment highly specific to the patient at hand, while the automated nature maintains operational simplicity.